Your browser doesn't support javascript.
loading
Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study.
Kastelein, John J P; Besseling, Joost; Shah, Sukrut; Bergeron, Jean; Langslet, Gisle; Hovingh, G Kees; Al-Saady, Naab; Koeijvoets, Michiel; Hunter, John; Johnson-Levonas, Amy O; Fable, Jennifer; Sapre, Aditi; Mitchel, Yale.
Afiliación
  • Kastelein JJ; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: j.j.kastelein@amc.uva.nl.
  • Besseling J; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Shah S; Clinical Research, Merck & Co, Inc, Kenilworth, NJ, USA.
  • Bergeron J; Endocrinology and Nephrology Unit, Centre Hospitalier Universitaire de Québec Research Centre, Laval University, Quebec City, QC, Canada.
  • Langslet G; Lipid Clinic, Medical Department, Oslo University Hospital, Oslo, Norway.
  • Hovingh GK; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Al-Saady N; Cardiovascular Metabolic, Covance, Sydney, Australia.
  • Koeijvoets M; Project Management, Covance, Rotterdam, Netherlands.
  • Hunter J; Biostatistics, Covance, Madison, WI, USA.
  • Johnson-Levonas AO; Scientific Affairs, Merck & Co, Inc, Kenilworth, NJ, USA.
  • Fable J; Clinical Research, Merck & Co, Inc, Kenilworth, NJ, USA.
  • Sapre A; Biostatistics, Merck & Co, Inc, Kenilworth, NJ, USA.
  • Mitchel Y; Clinical Research, Merck & Co, Inc, Kenilworth, NJ, USA.
Lancet ; 385(9983): 2153-61, 2015 May 30.
Article en En | MEDLINE | ID: mdl-25743173
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxazolidinonas / Hiperlipoproteinemia Tipo II / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxazolidinonas / Hiperlipoproteinemia Tipo II / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido